Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Resveratrol shown to bind to and cleave DNA

Dec. 29, 1998

U.S. clinical trials of SU-6668 slated for early 1999

Dec. 29, 1998

Isis obtains antisense cancer rights from Genzyme Molecular Oncology

Dec. 28, 1998

First convincing data for extended therapeutic gene expression by human stem cells

Dec. 28, 1998

In vivo safety and efficacy of photodynamic therapy evaluated by Theratechnologies in CML patients

Dec. 28, 1998

Gliadel Wafer approved in Canada and France

Dec. 28, 1998

New cancer-linked gene licensed by Corixa from MIT

Dec. 23, 1998

Preliminary phase II results for Incel + paclitaxel in refractory breast cancer

Dec. 23, 1998

Orphan drug status given to Immunomedics' CEA-Cide pancreatic cancer therapeutic

Dec. 23, 1998

Phase I results with GI-147211 establish MTD; phase II doses recommended

Dec. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...